EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Arsenic metabolism, diabetes prevalence, and insulin resistance among Mexican Americans: A mendelian randomization approach

Margaret C Weiss, Yu-Hsuan Shih, Molly Scannell Bryan, Brian P Jackson, David Aguilar, Eric L Brown, Goo Jun, Craig L Hanis, Maria Argos, Robert M Sargis

Environmental Advances · 2023-07 · 12 · 100361

DOI: 10.1016/j.envadv.2023.100361 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Environmental Advances, 2023-07. Verfasst von Margaret C Weiss und 9 weiteren Autor:innen. Beteiligte Einrichtung: School of Public Health, University of Illinois at Chicago, Chicago, IL, United States of America. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIDDK NIH HHS, NCATS NIH HHS, NIEHS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Differences in arsenic metabolism capacity may influence risk for type 2 diabetes, but the mechanistic drivers are unclear. We evaluated the associations between arsenic metabolism with overall diabetes prevalence and with static and dynamic measures of insulin resistance among Mexican Americans living in Starr County, Texas.

Methods

We utilized data from cross-sectional studies conducted in Starr County, Texas, from 2010-2014. A Mendelian randomization approach was utilized to evaluate the associations between arsenic metabolism and type 2 diabetes prevalence using the intronic variant in the arsenic methylating gene, rs9527, as the instrumental variable for arsenic metabolism. To further assess mechanisms for diabetes pathogenesis, proportions of the urinary arsenic metabolites were employed to assess the association between arsenic metabolism and insulin resistance among participants without diabetes. Urinary biomarkers of arsenic metabolites were modeled as individual proportions of the total. Arsenic metabolism was evaluated both with a static outcome of insulin resistance, homeostatic measure of assessment (HOMA-IR), and a dynamic measure of insulin sensitivity, Matsuda Index.

Results

Among 475 Mexican American participants from Starr County, higher metabolism capacity for arsenic is associated with higher diabetes prevalence driven by worse insulin resistance. Presence of the minor T allele of rs9527 is independently associated with an increase in the proportion of monomethylated arsenic (MMA%) and is associated with an odds ratio of 0.50 (95% CI: 0.24, 0.90) for type 2 diabetes. This association was conserved after potential covariate adjustment. Furthermore, among participants without type 2 diabetes, the highest quartile of MMA% was associated with 22% (95% CI: -33.5%, -9.07%) lower HOMA-IR and 56% (95% CI: 28.3%, 91.3%) higher Matsuda Index for insulin sensitivity.

Conclusions

Arsenic metabolism capacity, indicated by a lower proportion of monomethylated arsenic, is associated with increased diabetes prevalence driven by an insulin resistant phenotype among Mexican Americans living in Starr County, Texas.

Schlagwörter

Stichwörter der Autor:innen

ArsenicEndocrine disruptorInsulin resistanceInsulin sensitivityMethylationType 2 diabetes

Autor:innen und Institutionen

  • School of Public Health, University of Illinois at Chicago, Chicago, IL, United States of America.
  • College of Medicine, University of Illinois at Chicago, Chicago, IL, United States of America.
  • Institute for Minority Health Research, University of Illinois at Chicago, United States of America.
  • Center for Infectious Disease, University of Texas Health Science Center at Houston, Houston, TX, United States.
  • Department of Earth Sciences, Dartmouth College, Hanover, NH, United States of America.
  • Division of Cardiovascular Medicine, LSU Health School of Medicine, New Orleans, LA, United States.

Förderung

  • NIDDK NIH HHS
  • NCATS NIH HHS
  • NIEHS NIH HHS
  • NCI NIH HHS
  • NHLBI NIH HHS
  • NIGMS NIH HHS

Zitieren

APA

Weiss, M. C., Shih, Y. H., Bryan, M. S., Jackson, B. P., Aguilar, D., Brown, E. L., Jun, G., Hanis, C. L., Argos, M., & Sargis, R. M. (2023). Arsenic metabolism, diabetes prevalence, and insulin resistance among Mexican Americans: A mendelian randomization approach. Environmental Advances, 12, 100361. https://doi.org/10.1016/j.envadv.2023.100361

Vancouver

Weiss MC, Shih YH, Bryan MS, Jackson BP, Aguilar D, Brown EL, et al. Arsenic metabolism, diabetes prevalence, and insulin resistance among Mexican Americans: A mendelian randomization approach. Environmental Advances. 2023;12:100361. doi:10.1016/j.envadv.2023.100361

BibTeX
@article{Weiss2023,
  author = {Weiss, Margaret C and Shih, Yu-Hsuan and Bryan, Molly Scannell and Jackson, Brian P and Aguilar, David and Brown, Eric L and Jun, Goo and Hanis, Craig L and Argos, Maria and Sargis, Robert M},
  title = {Arsenic metabolism, diabetes prevalence, and insulin resistance among Mexican Americans: A mendelian randomization approach},
  journal = {Environmental Advances},
  year = {2023},
  volume = {12},
  pages = {100361},
  doi = {10.1016/j.envadv.2023.100361}
}
Kostenlos starten →